Immediate Treatment for Recurrent Pulmonary Embolism

Initial Risk Stratification

• The European Society of Cardiology recommends immediate assessment for hemodynamic instability to identify high-risk patients who may require urgent reperfusion therapy 1
• Bedside transthoracic echocardiography (TTE) should be performed as a fast, immediate step to differentiate suspected high-risk PE from other acute life-threatening situations 1

Immediate Treatment Based on Risk Category

High-Risk PE (with hemodynamic instability)

• Systemic thrombolytic therapy is recommended as first-line treatment for high-risk PE patients with hemodynamic instability 2

Intermediate/Low-Risk PE (without hemodynamic instability)

• The European Heart Journal recommends instituting anticoagulation therapy immediately while diagnostic workup is ongoing, unless bleeding or absolute contraindications exist 1
• Direct oral anticoagulants (DOACs) are preferred over vitamin K antagonists (VKAs) for initial treatment 3

Special Considerations for Recurrent PE

• Indefinite oral anticoagulant treatment is strongly recommended for recurrent venous thromboembolism not related to a major transient risk factor 3
• Inferior vena cava filters should be considered in cases of recurrent PE despite therapeutic anticoagulation 2

Monitoring and Follow-up

• For patients with intermediate-high-risk PE, a management strategy with a contingency plan should be prospectively planned if clinical deterioration occurs 1
• Regular assessment of medication adherence, drug tolerance, renal/hepatic function, and bleeding risk is necessary 3

Important Pitfalls to Avoid

• Anticoagulation should not be delayed while awaiting confirmatory diagnostic tests unless there are absolute contraindications 1
• DOACs should be avoided in patients with severe renal impairment, during pregnancy/lactation, or in those with antiphospholipid syndrome 2